In a matched case-control study of 472 postmenopausal women with a BRCA1 mutation, the adjusted odds ratio for breast cancer in HRT users versus nonusers was 0.58 (95% CI = 0.35 to 0.96; P = 0.03) [97]. Here, BRCA1 is linked to breast carcinoma.